Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis

BACKGROUND: Intravenous daratumumab (DARA IV) has been increasingly used in the treatment of amyloid light-chain (AL) amyloidosis. However, the outcomes for patients administered with DARA IV have not been aggregated. The objective of this systematic review and meta-analysis was to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chunyan, Wang, Xiaohong, Zhang, Renyi, Xu, Lingjie, Wang, Bin, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251945/
https://www.ncbi.nlm.nih.gov/pubmed/35788237
http://dx.doi.org/10.1186/s12935-022-02635-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251945/
https://www.ncbi.nlm.nih.gov/pubmed/35788237
http://dx.doi.org/10.1186/s12935-022-02635-6

Ejemplares similares